Announcement PDF BPH GLOBAL LTD ACN 009 104 330 Level 5, 126 Phillip Street, Sydney NSW 2000, Australia 5 September 2023 Company Announcements Pla�orm Australian Securi�es Exchange Joint venture with Singapore-based Chemokine Yuesheng Pte Ltd Highlights • • Joint venture agreement with a Singapore-based company with nutraceu�cal extrac�on technology and capability Development of two (2) products infused with nutraceu�cals extracted from birds’ nests and honey and mushroom extracts The Board of BPH Global Ltd (ASX: BP8) (Company) announces that today the Company has entered into a legally binding memorandum of understanding (JV Agreement) with Singapore-based company Chemokine Yuesheng Pte Ltd (Chemokine Yuesheng) for the joint development of two (2) birds nest related products: • A capsule form birds nest product incorpora�ng Australian honey extract; and • a nutraceu�cal form birds nest product incorpora�ng nutraceu�cals extracted from mushrooms (Projects) Chemokine Yuesheng is a member of a biotech group that specialises in and is dedicated to extrac�ng, formula�ng and developing proprietary bio-molecules from natural sources like honey, mushroom extract and Birds’ Nest. Chemokine Yuesheng’s aim in undertaking this R&D work is that these bio-molecules are validated with specific biological benefits to humans, par�cularly in cell signalling pathways associated with cellular defences against neuro-inflamma�on and cancers as well as in cell media�on pathways in immunological and haematological homeostasis associated with op�misa�on of the immune, haematological and neurological systems. Key terms of the agreement: • 12 months’ term with a right to extend for a further 12 months; • Chemokine Yuesheng to source birds’ nest products and undertake R&D ac�vi�es at its Singapore-based laboratory; • The Company to source honey and mushroom extract products from Australia; • Four (4) defined phases for the development and commercialisa�on ac�vi�es for each Project; • The budget for each Project is to be agreed between the par�es within 3 months of the date of execu�on of the JV Agreement. Ini�al establishment costs are to be shared equally; • The commercialisa�on terms for each Project are to be nego�ated and agreed by the par�es in the context of determining and agreeing the budget for each Project; • The JV Agreement contains provisions regarding intellectual property rights and confiden�ality undertakings, in par�cular: o o o • Intellectual property rights of a party that are shared for the purposes of the JV Agreement will remain the property of the original party that is the contributor or creator of such intellectual property; Intellectual property developed pursuant to the JV Agreement in respect of each Project (Project IP) is the joint property of the par�es; Undertakings to keep confiden�al any confiden�al informa�on of the other party that is exchanged between the par�es for the purposes of this Project Ether party can terminate on 3 months’ no�ce, except that if the budget in respect of each Project is not agreed by the par�es within 3 months of signing the JV Agreement, either party can terminate immediately. The JV Agreement represents a significant opportunity for the Company to partner with a quality, Singapore-based company in the development and commercialisa�on of high-end, birds’ nest-based products. The ini�al target markets are China and the ASEAN region. Chemokine Yuesheng brings its par�cular exper�se in nutraceu�cal and chemical extrac�on from birds-nest to the joint venture. The Company, in addi�on to its own nutraceu�cal extrac�on technologies will source honey and mushroom extract ingredients and products in Australia to enable the development and manufacture of high-end birds’ nest-based products. Sourcing honey and mushroom extract products will also enhance the saleability of products in China and other Asian-based markets. The Company and Chemokine Yuesheng will also consider the joint development of products containing nutraceu�cals extracted from seaweed. Ongoing updates The Company will provide further updates in due course on its progress with the Projects. - END Authorised for lodgement by the Board of the Company For further informa�on, please visit our website at www.bp8global.com or contact: Mr Paul Stephenson BPH Global Limited Chairman E: pauls@bp8global.com